Home
Search
BIO International Convention   |   June 3-6, 2024

Speakers & Presenters

All Speakers
By Count|Alphabetical
  • Show All
By Count|Alphabetical
  • Show All
By Count|Alphabetical
  • Show All
Company Type
  • Show All
Main Therapeutic Focus
  • Show All
Development Phase of Primary Product
  • Show All
Search Speakers
All Speakers
Filter by letter
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Results
Susie Harborth
CHIEF BUSINESS OFFICER, BREAKTHROUGH PROPERTIES
Life Sciences Ecosystems: Evolving Growth Patterns for Successful Incubation
San Diego, California, United States
Robert Hariri, MD, PhD
CHAIRPERSON, FOUNDER, AND CHIEF EXECUTIVE OFFICER, CELULARITY, INC.
The Future of Biotech Is Founder-Led
Debbie Hart
PRESIDENT & CEO, BIONJ
Student Day Welcome & Session
Placeholder Photo
Namir Hassan, PhD
CEO, ZELLUNA IMMUNOTHERAPY
Zelluna Immunotherapy
Oslo, Norway
Paul Hastings
PRESIDENT & CEO, NKARTA
The Life Sciences Industry: Taking a Public Health Approach to Ending the Gun Violence Epidemic
Shin Hatou, MD
CEO, CELLUSION
Cellusion Inc.
Tokyo, Tokyo, Japan
Sabine Haubenreisser, Ph.D, MSc
PRINCIPAL SCIENTIFIC ADMINISTRATOR, STAKEHOLDERS AND COMMUNICATIONS DIVISION, EUROPEAN MEDICINES AGENCY (EMA)
Friend or Foe: How COVID-19 Changed the Dynamic with Global Regulatory Agencies
Michael Havert, PhD
SENIOR VICE PRESIDENT, HEAD OF US REGULATORY, CELLULAR BIOMEDICINE GROUP, INC (CBMG)
Former FDA Reviewers Panel: Perspectives on Cell and Gene Therapy Development from Inside and Outside the FDA
Rockville, Maryland, United States
Kim Hawkins
GLOBAL HEAD OF CLINICAL PROJECT OPERATIONS & DOSSIER DELIVERY, SANOFI
Meta-Collaboration to Improve Decentralized Trial Excellence: Updates from the Collaboration Landscape
Rick Hawkins
CEO & CHAIRMAN, LUMOS PHARMA
Lumos Pharma
Austin, Texas, United States